Intervention Review

You have free access to this content

Linezolid versus vancomycin for skin and soft tissue infections

  1. Jirong Yue1,
  2. Bi Rong Dong1,*,
  3. Ming Yang1,
  4. Xiaomei Chen2,
  5. Taixiang Wu3,
  6. Guan J Liu4

Editorial Group: Cochrane Wounds Group

Published Online: 12 JUL 2013

Assessed as up-to-date: 9 MAY 2013

DOI: 10.1002/14651858.CD008056.pub2


How to Cite

Yue J, Dong BR, Yang M, Chen X, Wu T, Liu GJ. Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD008056. DOI: 10.1002/14651858.CD008056.pub2.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Geriatrics, Chengdu, Sichuan, China

  2. 2

    West China Hospital, Sichuan University, Department of Dermatology & Venereology, Chengdu, Sichuan, China

  3. 3

    West China Hospital, Sichuan University, Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials, Chengdu, Sichuan, China

  4. 4

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, Chengdu, Sichuan, China

*Bi Rong Dong, Department of Geriatrics, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. birongdong@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 JUL 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Buzelé, Linézolide : 12ans après, Journal des Anti-infectieux, 2014, 16, 4, 155

    CrossRef

  2. 2
    Evelina Tacconelli, Winfried V Kern, New antibiotics for skin and skin-structure infections, The Lancet Infectious Diseases, 2014, 14, 8, 659

    CrossRef

  3. 3
    P. Krishna, D. Srinivasulu, Venkata S Kotakadi, Synthesis, Characterization, and Antibacterial Activity of New Linezolid-Based Phosphoramidate Derivatives, Phosphorus, Sulfur, and Silicon and the Related Elements, 2014, 189, 10, 1557

    CrossRef